Advertisement
U.S. markets close in 1 hour 1 minute

Syndax Pharmaceuticals, Inc. (SNDX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
21.61-0.71 (-3.18%)
As of 02:59PM EDT. Market open.
Advertisement
Show:
Annual
Upgrade to begin using 40 years of financial statements and get so much more.

Income Statement

All numbers in thousands
Upgrade to begin using 40 years of financial statements and get so much more.
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
139,709
1,517
Operating Expense
229,954
229,954
151,757
113,489
72,940
Operating Income
-229,954
-229,954
-151,757
26,220
-71,423
Net Non Operating Interest Income Expense
20,955
20,955
2,735
-1,496
-1,516
Other Income Expense
-361
-361
-316
202
-219
Pretax Income
-209,360
-209,360
-149,338
24,926
-73,158
Net Income Common Stockholders
-209,360
-209,360
-149,338
24,926
-77,064
Diluted NI Available to Com Stockholders
-209,360
-209,360
-149,338
24,926
-77,064
Basic EPS
0.48
-2.98
-2.46
0.48
-1.87
Diluted EPS
0.46
-2.98
-2.46
0.48
-1.87
Basic Average Shares
52,065
70,371
60,761
52,065
41,308
Diluted Average Shares
53,623
70,371
60,761
52,065
41,308
Total Operating Income as Reported
-229,954
-229,954
-151,757
26,220
-71,423
Total Expenses
229,954
229,954
151,757
113,489
72,940
Net Income from Continuing & Discontinued Operation
-209,360
-209,360
-149,338
24,926
-73,158
Normalized Income
-209,360
-209,360
-149,338
24,926
-73,158
Interest Income
21,163
21,163
5,872
403
841
Interest Expense
208
208
3,137
1,899
2,357
Net Interest Income
20,955
20,955
2,735
-1,496
-1,516
EBIT
-209,152
-209,152
-146,201
26,825
-70,801
EBITDA
-209,140
-209,140
-146,168
26,868
-70,712
Reconciled Depreciation
12
12
33
43
89
Net Income from Continuing Operation Net Minority Interest
-209,360
-209,360
-149,338
24,926
-73,158
Normalized EBITDA
-209,140
-209,140
-146,168
26,868
-70,712
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0